Stockwatch: For what the clinical hold tolls
This article was originally published in Scrip
Executive Summary
If last week was anything to go by, the placing and lifting of clinical holds by the FDA has a dramatic effect on the share price of companies. Over the longer term, it seems that having been under the cloud of a clinical hold can adversely affect the commercial potential of a product.